[1]
M. Tanveer, N. Verma, S. Singh, J. Narayan, P. Kumar, and E. Ahmad, “Effect of Novel Biomarkers like Asprosin, Visfatin, and Subfatin in Cases of Metabolic Syndrome: A Systematic Review”, Hypertens J, vol. 10, no. 2, pp. 51–55, Jul. 2024.